Remission induced by Campath-1H for thymoma-associated agranulocytosis

Annals of Hematology

Volumn 83, Issue 6, 2004, Pages 398-400

  Alvares, C L ^a   Svasti Salee, D ^b   Rowley, M ^b   Gordon Smith, E C ^a   Marsh, J C W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KINGSTON HOSPITAL   (United Kingdom)

Author keywords

Agranulocytosis; Campath 1H; Monoclonal antibody; Thymoma

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; VINCRISTINE;

ADJUVANT THERAPY; ADULT; AGRANULOCYTOSIS; ARTICLE; CASE REPORT; DRUG RESPONSE; FATALITY; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAINTENANCE THERAPY; MALE; NEUTROPENIA; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; REMISSION; THYMECTOMY; THYMOMA; TREATMENT FAILURE; TREATMENT OUTCOME;

AGRANULOCYTOSIS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC AGENTS; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS; TREATMENT OUTCOME;

EID: 2542419011     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0834-7     Document Type: Article

References (13)

1. Calne R, Friend P, Moflatt S, Bradley A, Hale G, Firth J, Bradley J, Smith K, Waldmann H (1998) Prope tolerance perioperative Campath-1H, and low dose cyclosporin monotherapy in renal allograft recipients. Lancet 352:408
2. Coles AJ, Wing M, Smith S, Coraddu F, Greer S, Taylor C, Weetman A, Hale G, Chaterjee V, Waldmann H, Compston A (1999) Pulse monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 354:1691-1695
3. Hale G, Waldmann H (1996) Recent studies using Campath-1H antibodies to control GvHD and graft rejection. Bone Marrow Transplant 17:305-308
4. Isaacs JD, Watts RA, Hazelman BL, Hale G, Keogan MT, Cobbold SP, Wadmann H (1992) Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet 340:748-752
5. Killick SB, Marsh JCW, Hale G, Waldmann H, Kelly SJ, Gordon-Smith EC (1997) Sustained remission of severe resistant autoimmune neutropenia with Campath-1H. Br J Haematol 97:306-308
6. Marsh JCW, Gordon-Smith EC (2001) Campath-1H in the treatment of autoimmune cytopenias. Cytotherapy 3:189-195
7. Nagvekar N, Moody A, Moss P, Roxanis I, Curnow J, Beeson D, Pantic N, Newsom-Davis J, Vincent A, Wilcox N (1998) A pathogenetic role for the thymoma in myasthenia gravis. J Clin Invest 101:2268-2277
8. Reichman L, Clark M, Waldmann H, Winter G (1988) Reshaping human antibodies for therapy. Nature 332:323-327
9. Weir AB, Dow LW (1989) Response of agranulocytosis to thymectomy in a patient with thymoma and CLL. Med Paediatr Oncol 17:58-61
10. Wilcox NM, Schleup MA, Ritter HJ, Schuuman J, Newsom-Davis J, Christensson B (1987) Myasthenic and non-myasthenic thymoma. An expansion of minor cortical epithelial cell subsets? Am J Pathol 127:447-460
11. Willcox N (1993) Myasthenia gravis. Curr Opin Immunol 5:910-917
12. Willis F, Marsh JCW, Bevan D, Killick S, Lucas G, Griffiths R, Ouwehand W, Hale G, Waldmann H, Gordon-Smith EC (2001) The effect of treatment with Campath-1H in patients with autoimmune cytopenias. Br J Haematol 114:891-898
13. Yip D, Rasko JEJ, Lee C, Kronenberg H, O'Neill B (1996) Thymoma and agranulocytosis: two case reports and literature review. Br J Haematol 95:52-56